Lifevantage CORP

LifeVantage Corporation's annual meeting saw shareholders overwhelmingly re-elect all six director nominees and approve executive compensation on an advisory basis, while also ratifying Deloitte & Touche, LLP as auditors.

LifeVantage Corporation announced its first quarter fiscal year 2027 financial results, reporting a 22.0% decrease in revenue to $37.1 million and a net loss per diluted share of $0.02.

Lifevantage Corporation announces a strategic shift of its fiscal year-end from June 30 to December 31, effective September 29, 2026, to better align financial reporting with operational management.

LifeVantage Corporation announced a substantial year-over-year decrease in revenue and net income for its fourth fiscal quarter and full fiscal year 2026, citing macroeconomic pressures and product sales declines.

LifeVantage Corporation has adopted the 2026 New Employee Long-Term Incentive Plan to attract and retain key personnel.

LifeVantage Corporation reported a 25.2% decrease in third-quarter fiscal 2026 revenue to $43.7 million, primarily due to lower sales of its MindBody GLP-1 System.

LifeVantage Corporation reported a slight revenue increase and higher net income for the first quarter, driven by new product sales and lower tax expense, despite a decline in active customers and increased cash outflow from operations.

LifeVantage Corporation reports a significant increase in revenue for Q3 2025, primarily driven by the successful launch of its MindBody GLP-1 System.

LifeVantage Corporation reports a significant increase in revenue for the quarter ended December 31, 2024, primarily driven by the successful launch of its MindBody GLP-1 System.

LifeVantage Corporation's Q1 2025 results show a decrease in revenue compared to the same period last year, but an increase in net income.

LifeVantage Corporation's Q3 2024 results show a decrease in revenue compared to the same period last year, but an increase in net income.

LifeVantage Corporation's latest quarterly report shows a decrease in revenue and active accounts, alongside a net loss, but also highlights some positive developments in specific product lines and cost management.

LifeVantage Corporation's annual report for fiscal year 2026 indicates a substantial decrease in net revenue and active accounts, primarily driven by lower sales across key product lines.

LifeVantage Corporation announced a significant increase in net revenue and net income for fiscal year 2025, primarily driven by the successful launch of its new MindBody GLP-1 System.

LifeVantage Corporation's fiscal year 2024 saw a decrease in revenue, offset by new product launches and strategic initiatives.

Michael A Beindorff, a Director of Lifevantage Corp, received 17,888 shares of common stock on November 5, 2026.

Rajendran Anbalagan, a Director of Lifevantage Corp, received 17,888 shares of common stock on November 5, 2026.

Darwin Lewis, a Director of Lifevantage Corp, received 17,888 shares of common stock on November 5, 2026.

Raymond B Greer, a Director of Lifevantage Corp, received 17,888 shares of common stock on November 5, 2026.

Judd Dayton, a Director of Lifevantage Corp, received 17,888 shares of common stock on November 5, 2026.

Kristen Cunningham, Chief Sales Officer of Lifevantage Corp, reported multiple transactions in common stock on October 7, 2026.

LifeVantage Corporation has announced its Fiscal Year 2027 Annual Meeting of Stockholders will be held on November 5, 2026, to elect directors, vote on executive compensation, and ratify auditor appointments.

LifeVantage Corporation has filed a definitive proxy statement with the SEC for its upcoming shareholder meeting.

LifeVantage Corporation announced its fiscal year 2026 Annual Meeting of Stockholders, proposing director elections, executive compensation approval, auditor ratification, and an amendment to its 2017 Long-Term Incentive Plan, following a year of significant financial growth.

LifeVantage Corporation has filed a definitive proxy statement with the SEC related to its upcoming shareholder meeting.

LifeVantage Corporation's annual meeting of stockholders will be held on November 7, 2024, to vote on key proposals including director elections, executive compensation, and amendments to incentive plans.

The Capital Management Corporation has filed an updated Schedule 13G, confirming its beneficial ownership of 18.3% of LifeVantage Corporation's common stock as of September 30, 2026.

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported beneficial ownership of 5.31% of Lifevantage Corp's common stock as of April 1, 2026.

The Capital Management Corporation has increased its beneficial ownership of LifeVantage Corporation common stock to 14.9%, holding 1,878,411 shares.

The Capital Management Corporation has filed an amendment to its Schedule 13G, reporting a 19.1% beneficial ownership stake in LifeVantage Corporation.

BlackRock, Inc. has reported a 5.8% beneficial ownership stake in LifeVantage Corp, holding 732,063 shares of common stock.

The Capital Management Corporation has increased its beneficial ownership in LifeVantage Corporation to 16.3% of common stock.